iframe {
border: 1px solid #e4e5e6;
float:none !important

CEO Mark Capone talks about our mission, which is to answer patients’ four most pressing questions in six medical specialties.

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.